N. Gervois

发表

Synthetic anticancer vaccine candidates: rational design of antigenic peptide mimetics that activate tumor-specific T-cells.

N. Marchand-Geneste, F. Jotereau, Céline Douat-Casassus, 2007, Journal of medicinal chemistry.

Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by Chemotherapy

X. Sastre, N. Bercovici, S. Jacobelli, 2011, Clinical Cancer Research.

Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients

B. Dréno, A. Khammari, F. Jotereau, 2002, Cancer Immunology, Immunotherapy.

High neutralizing potency of swine glyco‐humanized polyclonal antibodies against SARS‐CoV‐2

R. Bruzzone, S. Conchon, S. Brouard, 2021, European journal of immunology.

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2

R. Bruzzone, S. Conchon, S. Brouard, 2020, bioRxiv.

Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas

B. Dréno, Y. Godet, A. Moreau-Aubry, 2010, PloS one.

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

F. Jotereau, E. Diéz, N. Gervois, 1996, The Journal of experimental medicine.

Adoptive transfer with high-affinity TCR to treat human solid tumors: how to improve the feasibility?

F. Jotereau, N. Labarrière, N. Gervois, 2012, Targeted Oncology.

PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting

F. Lang, F. Jotereau, N. Labarrière, 2007, Cancer Immunology, Immunotherapy.

Immunodominant Peptide Analogues CTL In Vitro by Selected Melan-A/MART-1 Enhanced Generation of Specific Tumor-Reactive

D. Valmori, F. Jotereau, J. Cerottini, 2017 .

Antigenic Peptide Immunodominant Melan-A/MART-1 HLA-A*0201-Restricted CTL Specific for the Diversity of the Fine Specificity Displayed by

P. Romero, D. Valmori, F. Jotereau, 1998 .

UT Receptor-Expressing Monocytes Urotensin II is a New Chemotactic Factor for and

P. Pacaud, N. Gervois, M. Rolli-Derkinderen, 2007 .

Increased frequency of nonconventional double positive CD4CD8 αβ T cells in human breast pleural effusions

F. Jotereau, N. Gervois, L. Derré, 2009, International journal of cancer.

Tumor‐reactive CD4+CD8αβ+ CD103+ αβT cells: A prevalent tumor‐reactive T‐cell subset in metastatic colorectal cancers

F. Jotereau, N. Gervois, G. Sarrabayrouse, 2011, International journal of cancer.

IL‐9 promotes the survival and function of human melanoma‐infiltrating CD4+CD8+ double‐positive T cells

B. Dréno, A. Khammari, N. Labarrière, 2016, European journal of immunology.

CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells

B. Dréno, A. Khammari, N. Labarrière, 2016, Oncoimmunology.

Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma.

P. Romero, D. Valmori, F. Jotereau, 1997, Journal of immunology.

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression

C. Volteau, A. Jarry, J. Mosnier, 2019, Modern Pathology.

Covalent modification of a melanoma-derived antigenic peptide with a natural quinone methide. Preliminary chemical, molecular modelling and immunological evaluation studies.

N. Marchand-Geneste, M. Bourguet-Kondracki, F. Jotereau, 2006, Molecular bioSystems.

[Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment].

A. Jarry, N. Gervois, C. Bossard, 2018, Bulletin du cancer.

HLA class II‐restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma‐infiltrating lymphocytes

B. Dréno, F. Jotereau, E. Diéz, 1995, European journal of immunology.

Urotensin II is a New Chemotactic Factor for UT Receptor-Expressing Monocytes1

P. Pacaud, N. Gervois, M. Rolli-Derkinderen, 2007, The Journal of Immunology.

Apoptotic body–loaded dendritic cells efficiently cross‐prime cytotoxic T lymphocytes specific for NA17‐A antigen but not for Melan‐A/MART‐1 antigen

F. Lang, F. Jotereau, N. Labarrière, 2002, International journal of cancer.

Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy1

F. Jotereau, E. Diéz, N. Gervois, 2002, The Journal of Immunology.

A single amino acid substitution in the Ak molecule fortuitously provokes an alloresponse

C. Benoist, D. Mathis, P. Dellabona, 1991, European journal of immunology.

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

D. Speiser, P. Romero, V. Cerundolo, 1999, International immunology.

High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells.

B. Dréno, F. Jotereau, N. Labarrière, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expression and Release of HLA-E by Melanoma Cells and Melanocytes: Potential Impact on the Response of Cytotoxic Effector Cells1

A. Moreau, A. Moreau-Aubry, F. Jotereau, 2006, The Journal of Immunology.

Human monocyte‐derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I‐restricted exogenous peptides

J. Delcros, F. Jotereau, G. Corradin, 1997, Immunology.

Selective expansion of a specific anti‐tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor‐infiltrating lymphocytes from a melanoma patient: Cytotoxic activity and T cell receptor gene rearrangements

F. Heuźe, F. Jotereau, E. Diéz, 1990, European journal of immunology.

Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma‐infiltrating lymphocytes

C. Viret, F. Jotereau, E. Diéz, 1992, European journal of immunology.

High proliferative capacity and specific antiautologous melanoma cytotoxicity of a human T-lymphocyte clone derived from tumor-infiltrating lymphocytes.

F. Heuźe, F. Jotereau, E. Diéz, 1990, Human immunology.

Soluble HLA-I/Peptide Monomers Mediate Antigen-Specific CD8 T Cell Activation through Passive Peptide Exchange with Cell-Bound HLA-I Molecules

K. Echasserieau, F. Lang, N. Labarrière, 2014, The Journal of Immunology.

Cell-Bound HLA-I Molecules through Passive Peptide Exchange with Antigen-Specific CD 8 T Cell Activation Soluble HLA-I / Peptide Monomers Mediate

K. Echasserieau, F. Lang, N. Labarrière, 2014 .

Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.

V. Vignard, N. Labarrière, D. Fradin, 2019, Cellular immunology.

Defective lymphokine production by most CD8+ and CD4+ tumor‐specific T cell clones derived from human melanoma‐infiltrating lymphocytes in response to autologous tumor cells in vitro

C. Viret, F. Jotereau, E. Diéz, 1994, European journal of immunology.

Impact on the Response of Cytotoxic Effector Melanoma Cells and Melanocytes : Potential Expression and Release of HLA-E by Francine Jotereau and

A. Moreau, A. Moreau-Aubry, F. Jotereau, 2006 .

Subopt imal Activation o f Melanoma Infiltrating Lymphocytes ( TIL ) due to Low Avidity

F. Jotereau, E. Diéz, N. Gervois, 2003 .

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.

J. Galmiche, H. Blottière, C. Bonnet, 2000, Gut.

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.

B. Dréno, V. Vignard, A. Khammari, 2017, Cancer research.

HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition

A. Cesbron-Gautier, M. Giral, P. Guerif, 2018, PLoS pathogens.

The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer

P. Gourraud, C. Brochier, A. Jarry, 2021, Cancers.

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

P. Romero, D. Valmori, F. Jotereau, 1998, Journal of immunology.

High-Density of FcγRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis

J. Mosnier, S. Bézieau, M. Péré, 2021, Frontiers in Oncology.

Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients

C. Retière, S. Conchon, S. Brouard, 2017, Front. Immunol..

Dominant TCR Vα usage by virus and tumor‐reactive T cells with wide affinity ranges for their specific antigens

M. Bonneville, L. Trautmann, P. Coulie, 2002, European journal of immunology.

Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition.

B. Baker, F. Jotereau, O. Borbulevych, 2010, Journal of medicinal chemistry.

Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer

B. Dréno, V. Vignard, A. Khammari, 2011, PloS one.

Mutations of the von Hippel–Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma

B. Escudier, N. Gervois, S. Gad, 2011, Oncogene.

Inhibition of antigen‐induced T cell response and antibody‐induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP‐1 and SHP‐2 protein‐tyrosine phosphatases

Eric Vivier, Francine Jotereau, G. Krystal, 1998, European journal of immunology.

Transcriptomic features of tumour-infiltrating CD4lowCD8high double positive αβ T cells in melanoma

B. Dréno, A. Khammari, D. Fradin, 2020, Scientific Reports.

Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide.

P. Romero, D. Valmori, F. Jotereau, 1998, Journal of immunology.

A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening

K. Echasserieau, F. Pecorari, M. Croyal, 2021, Scientific Reports.

HLA-E-Restricted Cross-Recognition of Allogeneic Endothelial Cells by CMV-Associated CD8 T Cells: A Potential Risk Factor following Transplantation

S. Nedellec, P. Tonnerre, E. Houssaint, 2012, PloS one.

Heterogeneity of biologic responses of melanoma-specific CTL.

F. Jotereau, E. Diéz, N. Gervois, 1997, Journal of immunology.

Structure of the TCR-Ag-MHC Complex

C. Benoist, J. Peccoud, D. Mathis, 1992 .

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

N. Segata, E. Le Chatelier, F. Ginhoux, 2023, Science.